Back
Ultragenyx Pharmaceutical Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17
RARE
Ultragenyx Pharmaceutical
Last Price:
$38.90
Seasonality Move:
11%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.04 | Sell |
| 20-day SMA: | 39.9 | Sell |
| 50-day SMA: | 41.81 | Sell |
| 200-day SMA: | 47.07 | Sell |
| 8-day EMA: | 38.96 | Sell |
| 20-day EMA: | 39.91 | Sell |
| 50-day EMA: | 41.74 | Sell |
| 200-day EMA: | 45.36 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.06 | Sell |
| Relative Strength Index (14 RSI): | 38.23 | Sell |
| Chaikin Money Flow: | 227575 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.7 - 42.4) | Sell |
| Bollinger Bands (100): | (40.65 - 48.05) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 37.98 while RARE 8-day simple moving average is 39.04, which is a Sell signal.
-
The stock price of RARE is 37.98 while Ultragenyx Pharmaceutical 20-day SMA is 39.90, which makes it a Sell.
-
Ultragenyx Pharmaceutical 50-day simple moving average is 41.81 while RARE share price is 37.98, making it a Sell technically.
-
RARE stock price is 37.98 and Ultragenyx Pharmaceutical 200-day simple moving average is 47.07, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
17
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a SellThe current Ultragenyx Pharmaceutical [RARE] share price is $37.98. The Score for RARE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.5B
Price in USD:
37.98
Share Volume:
976.7K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
36.71
Sell
17
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?The Ultragenyx Pharmaceutical stock price is 37.98 USD today.
-
Will RARE stock go up or go down?Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Ultragenyx Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 37.98 while RARE 8-day exponential moving average is 38.96, which is a Sell signal.
-
The stock price of RARE is 37.98 while Ultragenyx Pharmaceutical 20-day EMA is 39.91, which makes it a Sell.
-
Ultragenyx Pharmaceutical 50-day exponential moving average is 41.74 while RARE share price is 37.98, making it a Sell technically.
-
RARE stock price is 37.98 and Ultragenyx Pharmaceutical 200-day simple moving average is 45.36, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.74 per share, and an increase next year of $1.83 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
-
RARE Moving Average Covergence Divergence (MACD) indicator is -1.06, suggesting Ultragenyx Pharmaceutical is a Sell
-
Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 38.23, which suggest Ultragenyx Pharmaceutical is oversold
-
The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (38.7 - 42.4), which suggest Ultragenyx Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (40.65 - 48.05), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.